We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+35.16%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$20.1B
AUM Growth
+$3.92B
Cap. Flow
-$253M
Cap. Flow %
-1.26%
Top 10 Hldgs %
28.27%
Holding
390
New
38
Increased
100
Reduced
186
Closed
43

Top Buys

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$108M
2
ASAN icon
Asana
ASAN
+$77.4M
3
PINS icon
Pinterest
PINS
+$73.2M
4
ONEM
1Life Healthcare
ONEM
+$65.8M
5
TWLO icon
Twilio
TWLO
+$57.3M

Top Sells

Rank Stock Value
1
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$204M
2
RNG icon
RingCentral
RNG
+$139M
3
TSLA icon
Tesla
TSLA
+$114M
4
DXCM icon
DexCom
DXCM
+$70M
5
ZM icon
Zoom
ZM
+$64.7M

Sector Composition

Rank Sector Weight
1 Technology 27.93%
2 Healthcare 23.77%
3 Consumer Discretionary 20.21%
4 Communication Services 12.3%
5 Miscellaneous 5.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVET
326
DELISTED
Covetrus, Inc. Common Stock
CVET
$0 ﹤0.01%
8
GBT
327
DELISTED
Global Blood Therapeutics, Inc.
GBT
-7,028
Closed -$388K
EMWP
328
DELISTED
Eros Media World PLC
EMWP
-995
Closed -$44K
KL
329
CALL
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
-334,573
Closed -$16.3M
PFPT
330
DELISTED
Proofpoint, Inc.
PFPT
-45,441
Closed -$4.8M
NBLX
331
DELISTED
Noble Midstream Partners LP
NBLX
-910
Closed -$7K
PRVL
332
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
-5
Closed
MYOK
333
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-12,395
Closed -$1.69M
LVGO
334
DELISTED
Livongo Health, Inc. Common Stock
LVGO
-1,454,443
Closed -$204M
EAR
335
DELISTED
HEARUSA INC
EAR
$0 ﹤0.01%
375
DSL
336
DELISTED
DOWNEY FINANCIAL CORP(HLDG CO)
DSL
$0 ﹤0.01%
200
SVN
337
DELISTED
SUN-TIMES MEDIA GROUP INC.
SVN
$0 ﹤0.01%
650
PTA
338
DELISTED
PENN TREATY AMERICAN CORPORATION NEW
PTA
$0 ﹤0.01%
125

Similar funds

Gilder Gagnon Howe & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Gilder Gagnon Howe & Co held 390 positions worth $20.1B, up 24% from $16.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Gilder Gagnon Howe & Co's Q4 2020 filing shows 38 new, 100 increased, 186 reduced and 43 closed positions. Its largest new stake was Asana: 3,026,048 shares worth $89.4M. The largest sale was Livongo Health, Inc. Common Stock, an estimated $204M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Gilder Gagnon Howe & Co's largest Q4 2020 buy was Asana: 3,026,048 shares worth $89.4M.
  • Gilder Gagnon Howe & Co added most to Teladoc Health in Q4 2020, an estimated $108M increase.
  • Gilder Gagnon Howe & Co's biggest Q4 2020 reduction was RingCentral, cutting an estimated $139M.
  • Gilder Gagnon Howe & Co fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $204M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 28% of its $20.1B portfolio in Q4 2020.
  • Gilder Gagnon Howe & Co opened 38 new positions and closed 43 in Q4 2020.
  • Gilder Gagnon Howe & Co's portfolio value rose 24% quarter-over-quarter to $20.1B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2020, filed 16 Feb 2021.